Copper(II)-disulfiram loaded melanin-dots for cancer theranostics

Nanomedicine. 2021 Feb:32:102340. doi: 10.1016/j.nano.2020.102340. Epub 2020 Nov 21.

Abstract

Copper(II) diethyldithiocarbamate complex (CuET), the metabolite of disulfiram complexed with copper, is the component responsible for cancer treatment efficacy of disulfiram. But the hydrophobic property of CuET limits its use in vivo, and an appropriate drug delivery system needs to be developed. Ultrasmall melanin nanoparticle (M-Dot) with excellent biosafety and biocompatibility properties has been synthesized in our previous studies. Herein we prepared CuET loaded with M-Dots through hydrophobic interaction, which could enhance the water solubility significantly. After the administration of M-Dots-CuET in mice tumor models, the nanoparticles showed good tumor accumulation as evidenced by the enhanced photoacoustic signal in tumor regions. M-Dots-CuET also displayed excellent tumor inhibition capability, and the tumor growth inhibition value (TGI) was 45.1%. When combined with photothermal therapy, the TGI reached up to 78.6%. In summary, M-Dots-CuET provide a new potential strategy for cancer theranostics.

Keywords: Chemo/photothermal therapy; Copper (II) Disulfiram complex; Melanin nanoparticle; Theranostics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Copper / pharmacology*
  • Disulfiram / pharmacology*
  • Ditiocarb / chemistry
  • Female
  • Hyperthermia, Induced
  • Melanins / pharmacology*
  • Mice
  • Mice, Inbred BALB C
  • NIH 3T3 Cells
  • Nanoparticles / chemistry
  • Nanoparticles / ultrastructure
  • Neoplasms / therapy*
  • Photoacoustic Techniques
  • Phototherapy
  • Theranostic Nanomedicine*

Substances

  • Melanins
  • Copper
  • Ditiocarb
  • Disulfiram